Rosuvastatin 20mg
D3561C00004
Phase 3 small_molecule completed
Quick answer
Rosuvastatin 20mg for Homozygous Familial Hypercholesterolemia (HoFH) is a Phase 3 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Homozygous Familial Hypercholesterolemia (HoFH)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed